Drug Information

Drug General Information
Drug ID
D0I6EU
Former ID
DNC011806
Drug Name
PO3 2-Leu-Trp-O-3K
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551263]
Formula
C17H21K3N3O6P
Canonical SMILES
CC(C)CC(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)[O-])NP(=O)([O-<br />])[O-].[K+].[K+].[K+]
InChI
1S/C17H24N3O6P.3K/c1-10(2)7-14(20-27(24,25)26)16(21)19-15(17(22)23)8-11-9-18-13-6-4-3-5-12(11)13;;;/h3-6,9-10,14-15,18H,7-8H2,1-2H3,(H,19,21)(H,22,23)(H3,20,24,25,26);;;/q;3*+1/p-3/t14-,15-;;;/m0.../s1
InChIKey
WIPVJUNEQVFCAF-CEHYLXJWSA-K
PubChem Compound ID
44458238
Target and Pathway
Target(s) Endothelin-converting enzyme 1 Target Info Inhibitor [551263]
PANTHER Pathway Endothelin signaling pathway
WikiPathways SIDS Susceptibility Pathways
Corticotropin-releasing hormone
Endothelin Pathways
References
Ref 551263Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon, Bioorg. Med. Chem. Lett. 4(10):1257-1262 (1994).
Ref 551263Aminophosphonate endothelin converting enzyme inhibitors: potency-enhancing and selectivity-improving modifications of phosphoramidon, Bioorg. Med. Chem. Lett. 4(10):1257-1262 (1994).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.